Investigating the Possible Association between Toxoplasma gondii Infection and Multiple Sclerosis using a Combination of Serological and MRI Indices
DOI:
https://doi.org/10.35516/jmj.v59i3.1888الكلمات المفتاحية:
Toxoplasma gondii، Multiple Sclerosis ، Toxoplasma IgG and IgM antibodies، ELISA, Magnetic Resonance Imagingالملخص
Background: The present study was established to investigate if there is any association between multiple sclerosis (MS) and toxoplasmosis using a combination of serological and MRI indices.
Methods: 100 relapsing-remitting MS (RRMS) patients were recruited in the present study from the neurology clinic at Al-Bashir Hospital along with 34 age-matched healthy controls (HCs). MS patients as well as controls were tested for the presence of Toxoplasma IgG and IgM antibodies using ELISA technique. Magnetic resonance imaging (MRI) was performed on 1.5 T Siemens MR system. 3D T1 and T2 weighted images were acquired and processed to extract the white matter T2-lesion load.
Results: 86 RRMS patients (86%) and 12 HCs (35.3%) were tested positive for the T. gondii IgG antibodies. This difference in IgG seropositivity between MS patients and HCs was statistically significant (p<0.05). On the other hand, 19 RRMS patients (19%) and 4 HCs (11.7%) were tested positive for the Toxoplasma gondii IgM antibodies, and this difference was statistically insignificant (p >0.05). Neither IgG nor IgM concentration levels showed any significant association (p >0.05) with MS disease’s indices.
Conclusions: A strong significant association between the presence of anti-toxoplasma IgG antibodies and MS disease was found. Serum antibodies for T. gondii should be tested regularly among MS patients and anti-parasitic therapy should be provided, when necessary to prevent any reactivation and dissemination of the disease among these immunocompromised patients.
المراجع
Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30:1217.
https://doi.org/10.1016/S0020-7519(00)00124-7.
Innes. A brief history and overview of Toxoplasma gondii. Zoonoses Public Health 2010; 57:1–7. https://doi.org/10.1111/j.1863-2378.2009.01276.x.
Montoya J, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965–76.
https://doi.org/10.1016/S0140-6736(04)16412-X.
Barsoum RS. Parasitic infections in organ transplantation. Experimental and Clinical Transplantation 2004; 2:258–67.
Foroutan-Rad M, Majidiani H, Dalvand S, Daryani A, Kooti W, Saki J, et al. Toxoplasmosis in Blood Donors: A Systematic Review and Meta-Analysis. Transfus Med Rev 2016; 30:116–22. https://doi.org/10.1016/J.TMRV.2016.03.002.
Wormser GP, Tanowitz HB, Weiss LM. Toxoplasmosis: A Comprehensive Clinical Guide. vol. 34. Oxford Academic; 2002. https://doi.org/10.1086/340624.
Robert-Gangneux F, Dardé M. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012; 25:264–96. https://doi.org/10.1128/CMR.05013-11.
Mahadevan A, Arvinda Hanumantapura R, Satishchandra P, Avindra N, Udaykumar R, Shankar Susarla K. Neuropathological correlate of the “concentric target sign” in MRI of HIV associated cerebral toxoplasmosis. J Magn Reson Imaging 2013; 38:488.
https://doi.org/10.1002/JMRI.24036.
Roche AD, Rowley D, Brett FM, Looby S. Concentric and Eccentric Target MRI Signs in a Case of HIV-Associated Cerebral Toxoplasmosis. Case Rep Neurol Med 2018; 2018:1–3. https://doi.org/10.1155/2018/9876514.
Jamshaid Iqbal, Nabila Khalid. Detection of acute Toxoplasma gondii infection in early pregnancy by IgG avidity and PCR analysis. J Med Microbiol 2007; 56:1495–9.
https://doi.org/10.1099/JMM.0.47260-0.
Sakikawa M, Noda S, Hanaoka M, Nakayama H, Hojo S, Kakinoki S, et al. Anti-Toxoplasma Antibody Prevalence, Primary Infection Rate, and Risk Factors in a Study of Toxoplasmosis in 4,466 Pregnant Women in Japan. Clin Vaccine Immunol 2012; 19:365. https://doi.org/10.1128/CVI.05486-11.
Reiber H, Teut M, Pohl D, Rostasy K, Hanefeld F. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid. Mult Scler 2009; 15:1466–80. https://doi.org/10.1177/1352458509348418.
Ramagopalan S V., Sadovnick AD. Epidemiology of Multiple Sclerosis. Neurol Clin 2011; 29:207–17. https://doi.org/10.1016/J.NCL.2010.12.010.
Sinnecker T, Mittelstaedt P, Dörr J, Pfueller CF, Harms L, Niendorf T, et al. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study. Arch Neurol 2012; 69:739–45. https://doi.org/10.1001/ARCHNEUROL.2011.2450.
Schoonheim MM, Vigeveno RM, Lopes FCR, Pouwels PJW, Polman CH, Barkhof F, et al. Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline. Hum Brain Mapp 2014; 35:2348–58. https://doi.org/10.1002/HBM.22332.
Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006; 129:606–16. https://doi.org/10.1093/BRAIN/AWL007.
Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005; 162:767–73. https://doi.org/10.1176/APPI.AJP.162.4.767.
Zinger H, Sherer Y, Goddard G, Berkun Y, Barzilai O, Agmon-Levin N, et al. Common infectious agents prevalence in antiphospholipid syndrome. Lupus 2009; 18:1149–53.
https://doi.org/10.1177/0961203309345738.
Petríková J, Agmon-Levin N, Shapira Y, Barzilai O, Ram M, Gilburd B, et al. Prevalence of Toxoplasma antibodies among patients with various autoimmune diseases. Ann Rheum Dis 2010;69: A8–A8.
https://doi.org/10.1136/ARD.2010.129577T.
Arango M-T, Shoenfeld Y, Cervera R, Anaya J-M. Infection and autoimmune diseases, El Rosario University Press; 2013.
Carter CJ. Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders. J Pathog 2013; 2013:1–29.
https://doi.org/10.1155/2013/965046.
Serdar O, Fatima K, Hayri Demirbas, İnci Ç, Özge Yılmaz K, Özlem M, et al. Relationship of Toxoplasma Gondii Exposure with Multiple Sclerosis. Electronic Journal of General Medicine 2016; 13:58–63.
https://doi.org/10.15197/EJGM.01429.
Marjan S, Mehdi T. Seroepidemiological Study of Toxoplasma gondii in Patients with Multiple Sclerosis in Ahvaz, Southeastern Iran. Medical Laboratory Journal 2017; 11:6–9. https://doi.org/10.18869/acadpub.mlj.11.3.6.
Stascheit F, Paul F, Grittner U, Harms L, Rosche B. Toxoplasma gondii Seropositivity Is Negatively Associated With Multiple Sclerosis (P1.121). Neurology 2015;84.
Reza Saberi, Mehdi Sharif, Shahabeddin Sarvi, Sargis A Aghayan, Seyed Abdollah Hosseini, Davood Anvari, et al. Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis. J Neuroimmunol 2018; 322:57–62.
https://doi.org/10.1016/J.JNEUROIM.2018.06.011.
The role of Toxoplasma gondii in multiple sclerosis: A matched case-control study. | Neurology Asia | EBSCOhost n.d. https://openurl.ebsco.com/EPDB%3Agcd%3A11%3A18537051/detailv2?sid=ebsco%3Aplink%3Ascholar&id=ebsco%3Agcd%3A150990999&crl=c (accessed February 3, 2024).
Nicoletti A, Cicero CE, Giuliano L, Todaro V, Lo Fermo S, Chisari C, et al. Toxoplasma gondii and multiple sclerosis: a population-based case–control study. Scientific Reports 2020 10:1 2020; 10:1–7. https://doi.org/10.1038/s41598-020-75830-y.
Serdar O, Fatima K, Hayri Demirbas, İnci Ç, Özge Yılmaz K, Özlem M, et al. Relationship of Toxoplasma Gondii Exposure with Multiple Sclerosis. Electronic Journal of General Medicine 2016; 13:58–63.
https://doi.org/10.15197/EJGM.01429.
Marjan S, Mehdi T. Seroepidemiological Study of Toxoplasma gondii in Patients with Multiple Sclerosis in Ahvaz, Southeastern Iran. Medical Laboratory Journal 2017; 11:6–9. https://doi.org/10.18869/acadpub.mlj.11.3.6.
Stascheit F, Paul F, Grittner U, Harms L, Rosche B. Toxoplasma gondii Seropositivity Is Negatively Associated With Multiple Sclerosis (P1.121). Neurology 2015;84.
Koskderelioglu A, Afsar I, Pektas B, Gedizlioglu M. Is Toxoplasma gondii infection protective against multiple sclerosis risk? Mult Scler Relat Disord 2017; 15:7–10.
https://doi.org/10.1016/J.MSARD.2017.04.004.
Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load: A 3-Tesla Magnetic Resonance Imaging Study. Clin Neuroradiol 2019; 29:51–64. https://doi.org/10.1007/S00062-017-0654-0.
Delogu LG, Deidda S, Delitala G, Manetti R. Infectious diseases and autoimmunity. J Infect Dev Ctries 2011; 5:679–87.
https://doi.org/10.3855/JIDC.2061.
Schlüter D, Barragan A. Advances and Challenges in Understanding Cerebral Toxoplasmosis. Front Immunol 2019;10.
https://doi.org/10.3389/FIMMU.2019.00242.
Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 2002; 8:634–40.
https://doi.org/10.1046/J.1469-0691.2002.00485.X.
Reza Saberi, Mehdi Sharif, Shahabeddin Sarvi, Sargis A Aghayan, Seyed Abdollah Hosseini, Davood Anvari, et al. Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis. J Neuroimmunol 2018; 322:57–62.
